Literature DB >> 26552033

Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury.

Sureerat Suwatcharangkoon1, Emma Meyers2, Cristina Falo2, J Michael Schmidt2, Sachin Agarwal2, Jan Claassen2, Stephan A Mayer3.   

Abstract

IMPORTANCE: Loss of consciousness (LOC) is a common presenting symptom of subarachnoid hemorrhage (SAH) that is presumed to result from transient intracranial circulatory arrest.
OBJECTIVE: To clarify the association between LOC at onset of SAH, complications while in the hospital, and long-term outcome after SAH. DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis was conducted of 1460 consecutively treated patients with spontaneous SAH who were part of a prospective observational cohort study at a large urban academic medical center (the Columbia University SAH Outcomes Project or SHOP). Patients were enrolled between August 6, 1996, and July 23, 2012. Analysis was conducted from December 1, 2013, to February 28, 2015. EXPOSURES: Loss of consciousness at onset was identified by structured interview of the patient and first responders. Patients (80.5%) were observed for up to 1 year to assess functional recovery. MAIN OUTCOMES AND MEASURES: Modified Rankin scale scores were assigned based on telephone or in-person interviews of the patient, family members, or caregivers. Complications while in the hospital were predefined and adjudicated by the study team.
RESULTS: Five hundred ninety patients (40.4%) reported LOC at onset of SAH. Loss of consciousness was associated with poor clinical grade, more subarachnoid and intraventricular blood seen on admission computed tomographic scan, and a higher frequency of global cerebral edema (P < .001). Loss of consciousness was also associated with more prehospital tonic-clonic activity (22.7% vs 4.2%; P < .001) and cardiopulmonary arrest (9.7% vs 0.5%, P < .001) vs patients who did not experience LOC. In multivariable analysis, death or severe disability at 12 months was independently associated with LOC after adjusting for established risk factors for poor outcome, including poor admission clinical grade (adjusted odds ratio, 1.94; 95% CI, 1.38-2.72; P < .001). There was no association between LOC at onset and delayed cerebral ischemia or aneurysm rebleeding. CONCLUSIONS AND RELEVANCE: Loss of consciousness at symptom onset is an important manifestation of early brain injury after SAH and a predictor of death or poor functional outcome at 12 months.

Entities:  

Mesh:

Year:  2016        PMID: 26552033     DOI: 10.1001/jamaneurol.2015.3188

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  27 in total

1.  Bedside quantitative electroencephalography improves assessment of consciousness in comatose subarachnoid hemorrhage patients.

Authors:  Jan Claassen; Angela Velazquez; Emma Meyers; Jens Witsch; M Cristina Falo; Soojin Park; Sachin Agarwal; J Michael Schmidt; Nicholas D Schiff; Jacobo D Sitt; Lionel Naccache; E Sander Connolly; Hans-Peter Frey
Journal:  Ann Neurol       Date:  2016-08-16       Impact factor: 10.422

2.  Melatonin attenuates early brain injury after subarachnoid hemorrhage by the JAK-STAT signaling pathway.

Authors:  Shengli Li; Song Yang; Bin Sun; Chunhua Hang
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

3.  The Acute Phase of Experimental Subarachnoid Hemorrhage: Intracranial Pressure Dynamics and Their Effect on Cerebral Blood Flow and Autoregulation.

Authors:  Catharina Conzen; Katrin Becker; Walid Albanna; Miriam Weiss; Annika Bach; Nyanda Lushina; André Steimers; Sarah Pinkernell; Hans Clusmann; Ute Lindauer; Gerrit A Schubert
Journal:  Transl Stroke Res       Date:  2018-11-15       Impact factor: 6.829

4.  Hematologic counts as predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Ivan Rocha Ferreira Da Silva; Joao Antonio Gomes; Ari Wachsman; Gabriel Rodriguez de Freitas; Jose Javier Provencio
Journal:  J Crit Care       Date:  2016-09-22       Impact factor: 3.425

5.  DLK silencing attenuated neuron apoptosis through JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats.

Authors:  Cheng Yin; Guang-Fu Huang; Xiao-Chuan Sun; Zongduo Guo; John H Zhang
Journal:  Neurobiol Dis       Date:  2017-04-08       Impact factor: 5.996

6.  Desmopressin administration and rebleeding in subarachnoid hemorrhage: analysis of an observational prospective database.

Authors:  Charles L Francoeur; David Roh; J Michael Schmidt; Stephan A Mayer; M Cristina Falo; Sachin Agarwal; E Sander Connolly; Jan Claassen; Mitchell S V Elkind; Soojin Park
Journal:  J Neurosurg       Date:  2018-01-01       Impact factor: 5.115

7.  Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats.

Authors:  Cheng Yin; Guang-Fu Huang; Xiao-Chuan Sun; Zongduo Guo; John H Zhang
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

8.  Automated Quantification of Reduced Sulcal Volume Identifies Early Brain Injury After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Jane Y Yuan; Yasheng Chen; Atul Kumar; Zach Zlepper; Keshav Jayaraman; Wint Y Aung; Julian V Clarke; Michelle Allen; Umeshkumar Athiraman; Joshua Osbun; Gregory J Zipfel; Rajat Dhar
Journal:  Stroke       Date:  2021-02-16       Impact factor: 7.914

9.  Tocilizumab Reduces Vasospasms, Neuronal Cell Death, and Microclot Formation in a Rabbit Model of Subarachnoid Hemorrhage.

Authors:  Davide M Croci; Stefan Wanderer; Fabio Strange; Basil E Grüter; Sivani Sivanrupan; Lukas Andereggen; Daniela Casoni; Michael von Gunten; Hans Rudolf Widmer; Stefano Di Santo; Javier Fandino; Luigi Mariani; Serge Marbacher
Journal:  Transl Stroke Res       Date:  2021-01-06       Impact factor: 6.829

Review 10.  Neurocritical care management of poor-grade subarachnoid hemorrhage: Unjustified nihilism to reasonable optimism.

Authors:  Fawaz Al-Mufti; Stephan A Mayer; Gurmeen Kaur; Daniel Bassily; Boyi Li; Matthew L Holstein; Jood Ani; Nicole E Matluck; Haris Kamal; Rolla Nuoman; Christian A Bowers; Faizan S Ali; Hussein Al-Shammari; Mohammad El-Ghanem; Chirag Gandhi; Krishna Amuluru
Journal:  Neuroradiol J       Date:  2021-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.